找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

ESCI期刊Contemporary Clinical Trials Communications 2024/2025影响因子:1.461 (CONT CLIN TRIAL COMM) (NULL). (MEDICINE, RESEARC

[复制链接]
楼主: Assert
发表于 2025-3-23 12:25:03 | 显示全部楼层
Submitted on: 27 May 2021. Revised on: 07 July 2021. Accepted on: 20 July 2021. ___________________Contemporary Clinical Trials Communications
发表于 2025-3-23 16:54:47 | 显示全部楼层
Submitted on: 09 August 2001. Revised on: 20 September 2001. Accepted on: 25 October 2001. ___________________Contemporary Clinical Trials Communications
发表于 2025-3-23 18:40:04 | 显示全部楼层
发表于 2025-3-23 22:58:31 | 显示全部楼层
Submitted on: 10 February 2017. Revised on: 11 May 2017. Accepted on: 24 May 2017. ___________________Contemporary Clinical Trials Communications
发表于 2025-3-24 04:38:26 | 显示全部楼层
发表于 2025-3-24 07:03:33 | 显示全部楼层
Submitted on: 28 October 2009. Revised on: 18 December 2009. Accepted on: 31 January 2010. ___________________Contemporary Clinical Trials Communications
发表于 2025-3-24 13:46:56 | 显示全部楼层
发表于 2025-3-24 15:19:01 | 显示全部楼层
发表于 2025-3-24 19:36:40 | 显示全部楼层
发表于 2025-3-25 01:52:31 | 显示全部楼层
Submitted on: 13 November 2020. Revised on: 01 January 2021. Accepted on: 26 January 2021. ___________________Contemporary Clinical Trials Communications
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 07:57
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表